The rapid molecular chlamydia and gonorrhea self-test provides results in 30 minutes from a self-collected swab sample, the firm said.

Last week, readers were most interested in a story about concerns around BillionToOne's Unity NIPT due to false negative results.

Abbott's Exact Sciences buy, Blackstone and TPG's Hologic acquisition, and Water's BD transaction could herald a busy 2026 ...

The Florida company's Kiffik K-Exp platform enables continuous access to interstitial fluid for longitudinal molecular diagnostic testing.

The SD Biosensor Standard Q COVID-19 Ag Test and Acon Biotech Flowflex SARS-CoV-2 Antigen Rapid Test were previously listed under WHO's emergency use listing.

NEW YORK – In a year when the broader economy put pressure on many diagnostics firms, stories about how some companies ultimately succumbed to macroeconomic forces grabbed readers' interest, as did ...

NEW YORK – Increased commercial alliances, regulatory clearances, and academic evaluations helped advance digital pathology into the mainstream in 2025 and toward further adoption in the coming years.

NEW YORK – Italian in vitro diagnostics firm Diasorin said on Sunday that the US Food and Drug Administration has issued 510(k) clearance and CLIA-waived the firm's first assay for use on the Liaison ...

NEW YORK - The US Food and Drug Administration granted 510(k) marketing clearances in November to Roche Molecular Systems, Cytovale, Truvian Health, and others for infectious disease pathogen ...